[8-K] Walgreens Boots Alliance, Inc Reports Material Event

Rhea-AI Filing Summary

Walgreens Boots Alliance (Nasdaq: WBA) filed a Form 8-K under Item 2.02 to furnish its fiscal third-quarter 2025 results (quarter ended May 31 2025). A detailed press release is attached as Exhibit 99.1 and incorporated by reference; the body of the 8-K contains no financial tables. The information is "furnished," not "filed," avoiding Section 18 liability. No guidance revisions, strategic transactions or other material events were disclosed. The sole purpose is compliance with Regulation FD—making the earnings release simultaneously available to all investors. The report was signed by CFO Manmohan Mahajan on June 26 2025.

Insights

Financial Analyst

Quarterly numbers furnished, details pending; impact unknown until Exhibit 99.1 is reviewed—routine yet potentially market-moving.

The 8-K simply alerts the market that Walgreens Boots Alliance has released fiscal Q3 2025 results. Because the actual income-statement and cash-flow figures reside only in Exhibit 99.1, investors must examine that attachment to gauge revenue, EPS and margin trends. Marking the data as "furnished" shields the company from Section 18 liability and indicates no restatement or correction. Absent explicit commentary on guidance, restructuring or legal contingencies, the filing itself offers no directional clues. Nevertheless, earnings releases typically drive short-term price discovery; traders will focus on U.S. retail pharmacy comps, cost-saving progress and free-cash-flow conversion once the exhibit is read. Pending that review, the disclosure is neutral.

Corporate Governance Expert

Item 2.02 filing limits liability, meets Reg FD; no governance actions—impact neutral.

The company demonstrates good disclosure hygiene by furnishing its earnings release through an 8-K, ensuring equal access to material information. By opting to "furnish" rather than "file," WBA complies with SEC rules while minimizing litigation exposure. The document contains no board or C-suite changes, no amendments to organizational documents and no mention of new material agreements or litigation. Signature by the CFO satisfies Rule 12b-15 requirements, indicating standard internal controls. With no governance red flags or compliance issues introduced, the event is routine from a stewardship perspective and does not alter the shareholder risk profile.

false 0001618921 0001618921 2025-06-26 2025-06-26 0001618921 us-gaap:CommonStockMember 2025-06-26 2025-06-26 0001618921 wba:M3.600WalgreensBootsAllianceInc.NotesDue20252Member 2025-06-26 2025-06-26 0001618921 wba:M2.125WalgreensBootsAllianceInc.NotesDue20261Member 2025-06-26 2025-06-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 26, 2025

WALGREENS BOOTS ALLIANCE, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-36759		47-1758322
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification Number)

108 Wilmot Road, Deerfield, Illinois				60015
(Address of principal executive offices)				(Zip Code)

Registrant’s telephone number, including area code: (847) 315-3700

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		WBA		The Nasdaq Stock Market LLC
3.600% Walgreens Boots Alliance, Inc. notes due 2025		WBA25		The Nasdaq Stock Market LLC
2.125% Walgreens Boots Alliance, Inc. notes due 2026		WBA26		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On June 26, 2025, Walgreens Boots Alliance, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter ended May 31, 2025 and related matters. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference.

The information in this Item 2.02, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such disclosure in this Form 8-K in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit		Description
99.1		Press Release of Walgreens Boots Alliance, Inc. dated June 26, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				WALGREENS BOOTS ALLIANCE, INC.
Date: June 26, 2025				By:		/s/ Manmohan Mahajan
				Title:		Global Chief Financial Officer

FAQ

When did WBA publish its fiscal Q3 2025 earnings release?

Walgreens Boots Alliance furnished its fiscal Q3 2025 results on June 26 2025 via Form 8-K.

What reporting period is covered by WBA’s latest results?

The release covers the quarter ended May 31 2025, WBA’s fiscal third quarter.

Which Form 8-K item does WBA use for the disclosure?

WBA utilized Item 2.02 – Results of Operations and Financial Condition to furnish the information.

Where can investors find detailed revenue and EPS figures?

Full financial metrics are contained in Exhibit 99.1 attached to the Form 8-K.

Did WBA update its guidance or announce strategic changes in this filing?

No. The 8-K solely furnishes the earnings release and does not mention guidance revisions or strategic actions.